Autonomic Dysreflexia in Spinal Cord Injuries: UDS Filling Speed Impact

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorPusan National University Yangsan Hospital

About this trial

In patients with spinal cord injury, the investigators want to understand and understand the differences in AD prevalence and characteristics according to bladder injection rate, and to determine which factors have a greater influence between bladder expansion or injection rate.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with chronic spinal cord injury 6 months after receiving the award

Patients with confirmed AD due to bladder fullness in previous urodynamic test

Patients confirmed to have neurological damage level C1-T6, AIS A or B

Disqualifiers

Patients who cannot perform the test because their systolic blood pressure remains at 150 mmHg during the urodynamic test

Patients who cannot undergo testing due to hemodynamic instability

Patients who cannot undergo testing due to overt urinary tract infection

Trial population

Chronic spinal cord injuries

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • Urodynamic test

    Other intervention

    Urodynamic testing is performed using saline solution at the same temperature as body temperature (37 degrees) at two injection speeds of 10 mL/min and 100 mL/min, respectively.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Bladder volume (ml)

(1) at first AD at an infusion rate of 10 mL/min (2) at first AD at an infusion rate of 100 mL/min

Time frame
Immediately after the test

Secondary outcomes

1

Bladder compliance (mL/cmH2O)

Bladder compliance

Time frame
Immediately after the test
2

Symptoms (Y/N)

Symptoms

Time frame
Immediately after the test
3

Blood pressure (mmHg)

Blood pressure

Time frame
Immediately after the test
4

Heart rate (bpm)

Heart rate

Time frame
Immediately after the test

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.